NO20032491L - Krystallinsk glukosamin sulfat metall salter - Google Patents
Krystallinsk glukosamin sulfat metall salterInfo
- Publication number
- NO20032491L NO20032491L NO20032491A NO20032491A NO20032491L NO 20032491 L NO20032491 L NO 20032491L NO 20032491 A NO20032491 A NO 20032491A NO 20032491 A NO20032491 A NO 20032491A NO 20032491 L NO20032491 L NO 20032491L
- Authority
- NO
- Norway
- Prior art keywords
- metal salts
- glucosamine sulfate
- crystalline glucosamine
- novel crystalline
- sulfate metal
- Prior art date
Links
- 229910052751 metal Inorganic materials 0.000 title abstract 9
- 239000002184 metal Substances 0.000 title abstract 9
- MTDHILKWIRSIHB-UHFFFAOYSA-N (5-azaniumyl-3,4,6-trihydroxyoxan-2-yl)methyl sulfate Chemical compound NC1C(O)OC(COS(O)(=O)=O)C(O)C1O MTDHILKWIRSIHB-UHFFFAOYSA-N 0.000 title abstract 5
- 229960002849 glucosamine sulfate Drugs 0.000 title abstract 5
- 150000003839 salts Chemical class 0.000 title abstract 5
- 239000002904 solvent Substances 0.000 abstract 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- 208000025747 Rheumatic disease Diseases 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 230000002917 arthritic effect Effects 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000030159 metabolic disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
- 230000000552 rheumatic effect Effects 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
- C07H5/06—Aminosugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Physical Education & Sports Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Foreliggende oppfinnelse angår nye krystallinske glukosamin sulfat metall salter for anvendelse i behandling av akutte og kroniske former for reumatiske og artritiske sykdommer og alle de patologiske og tilstandene som har opprinnelse i metabolske forstyrrelser av de osteo-artikulære vevene. Mer spesifikt angår foreliggende oppfinnelse nye krystallinske glukosamin sulfat metall salter som har et lavt metall innhold der metallet enten kan være natrium eller kalium. Foreliggende oppfinnelse angår videre en oppløsningsmiddel-basert og en oppløsningmiddel-basert fremgangsmåte for fremstilling av de nye krystallinske glukosamin sulfat metall saltene som har lavt metall innhold og farmasøytiske sammensetninger som omfatter de nye krystallinske glukosamin sulfat metall saltene som har lavt metall innhold.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1088MU2000 | 2000-12-01 | ||
| IN1087MU2000 | 2000-12-01 | ||
| IN394MU2001 | 2001-04-26 | ||
| PCT/IN2001/000211 WO2002043653A2 (en) | 2000-12-01 | 2001-12-03 | Crystalline glucosamine sulphate metal salts |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20032491D0 NO20032491D0 (no) | 2003-06-02 |
| NO20032491L true NO20032491L (no) | 2003-07-30 |
| NO324847B1 NO324847B1 (no) | 2007-12-17 |
Family
ID=27272463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20032491A NO324847B1 (no) | 2000-12-01 | 2003-06-02 | Krystallinske glukosamin sulfat metall salter |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US6812223B2 (no) |
| EP (1) | EP1347986B1 (no) |
| JP (1) | JP4307072B2 (no) |
| KR (1) | KR100842400B1 (no) |
| CN (1) | CN100351261C (no) |
| AT (1) | ATE293122T1 (no) |
| AU (2) | AU2002217416B2 (no) |
| BG (1) | BG107845A (no) |
| BR (1) | BR0115801A (no) |
| CA (1) | CA2436925C (no) |
| CZ (1) | CZ20031503A3 (no) |
| DE (1) | DE60110118T2 (no) |
| DK (1) | DK1347986T3 (no) |
| DZ (1) | DZ3450A1 (no) |
| EA (1) | EA006632B1 (no) |
| ES (1) | ES2240570T3 (no) |
| HR (1) | HRP20030400A2 (no) |
| HU (1) | HU229546B1 (no) |
| IL (2) | IL156100A0 (no) |
| MA (1) | MA25925A1 (no) |
| MX (1) | MXPA03004693A (no) |
| NO (1) | NO324847B1 (no) |
| NZ (1) | NZ526079A (no) |
| PL (1) | PL207740B1 (no) |
| PT (1) | PT1347986E (no) |
| RO (1) | RO121738B1 (no) |
| SI (1) | SI21188A (no) |
| SK (1) | SK285926B6 (no) |
| WO (1) | WO2002043653A2 (no) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20012818A1 (it) * | 2001-12-28 | 2003-06-28 | Acraf | Un metodo per preparare un composto della glucosammina e composto cosi ottenuto |
| JP2006508643A (ja) | 2002-07-01 | 2006-03-16 | アーキオン ライフ サイエンシーズ エルエルシー ディー／ビー／エー バイオ−テクニカル リソーセズ ディビジョン | グルコサミンおよびｎ−アセチルグルコサミン製造のためのプロセスおよび材料 |
| US7388001B1 (en) | 2004-09-17 | 2008-06-17 | Jfc Technolries, Llc | Halide-free glucosamine sulfate compositions and methods of preparation |
| US7683042B1 (en) | 2004-09-17 | 2010-03-23 | Jfc Technologies, Llc | Stabilized halide-free glucosamine base and method of preparation |
| US7388000B1 (en) | 2004-09-17 | 2008-06-17 | Jfct Technologies, Llc | Halide-free glucosamine phosphate compositions and methods of preparation |
| US7622576B1 (en) | 2004-09-22 | 2009-11-24 | Jfc Technologies, Llc | Halide-free glucosamine base and method of preparation |
| DE102005033844A1 (de) * | 2005-07-20 | 2007-02-01 | Beiersdorf Ag | Insektenabwehrmittel mit Langzeitwirkung |
| US7854956B2 (en) * | 2007-03-07 | 2010-12-21 | Exportadora De Sal, S.A. De C.V. | Low sodium salt compositions and methods of preparation and uses thereof |
| CN101735283B (zh) * | 2008-11-14 | 2012-07-18 | 徐州海吉亚生物制品有限公司 | 一种氨基葡萄糖盐酸盐与氨基葡萄糖硫酸钾/钠盐的共结晶技术 |
| CA2779168A1 (en) * | 2009-11-05 | 2011-05-12 | Pharma Base India Pvt. Ltd. | Process for preparing a mixed salt of glucosamine sulfate and an alkali metal chloride |
| CN106866751B (zh) * | 2017-02-17 | 2019-11-05 | 江苏双林海洋生物药业有限公司 | 一种硫酸氨基葡萄糖复盐的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1148050B (it) * | 1981-04-30 | 1986-11-26 | Rotta Research Lab | Composto stabile della glucosamina solfato procedimento per la sua preparazione e composizioni farmaceutiche contenenti tale composto |
| DE3532081A1 (de) * | 1985-09-09 | 1987-03-12 | Orion Yhtymae Oy | Mischsalze von glucosaminsulfat und verfahren zu ihrer herstellung |
| CH690719A5 (it) * | 1996-08-19 | 2000-12-29 | Rotta Res B V Amsterdam Swiss | Procedimento per la preparazione di sali misti della glucosamina. |
| US5843923A (en) * | 1998-05-22 | 1998-12-01 | Jame Fine Chemicals, Inc. | Glucosamine sulfate potassium chloride and process of preparation thereof |
-
2001
- 2001-12-03 DZ DZ013450A patent/DZ3450A1/fr active
- 2001-12-03 EP EP01998306A patent/EP1347986B1/en not_active Expired - Lifetime
- 2001-12-03 MX MXPA03004693A patent/MXPA03004693A/es active IP Right Grant
- 2001-12-03 DK DK01998306T patent/DK1347986T3/da active
- 2001-12-03 US US10/433,317 patent/US6812223B2/en not_active Expired - Fee Related
- 2001-12-03 JP JP2002545632A patent/JP4307072B2/ja not_active Expired - Fee Related
- 2001-12-03 CN CNB018196926A patent/CN100351261C/zh not_active Expired - Fee Related
- 2001-12-03 DE DE60110118T patent/DE60110118T2/de not_active Expired - Lifetime
- 2001-12-03 PT PT01998306T patent/PT1347986E/pt unknown
- 2001-12-03 BR BR0115801-5A patent/BR0115801A/pt active Search and Examination
- 2001-12-03 RO ROA200300464A patent/RO121738B1/ro unknown
- 2001-12-03 SK SK648-2003A patent/SK285926B6/sk not_active IP Right Cessation
- 2001-12-03 AU AU2002217416A patent/AU2002217416B2/en not_active Ceased
- 2001-12-03 WO PCT/IN2001/000211 patent/WO2002043653A2/en active Search and Examination
- 2001-12-03 IL IL15610001A patent/IL156100A0/xx unknown
- 2001-12-03 KR KR1020037007342A patent/KR100842400B1/ko not_active IP Right Cessation
- 2001-12-03 NZ NZ526079A patent/NZ526079A/en not_active IP Right Cessation
- 2001-12-03 SI SI200120069A patent/SI21188A/sl not_active IP Right Cessation
- 2001-12-03 CA CA002436925A patent/CA2436925C/en not_active Expired - Fee Related
- 2001-12-03 PL PL366386A patent/PL207740B1/pl unknown
- 2001-12-03 AT AT01998306T patent/ATE293122T1/de not_active IP Right Cessation
- 2001-12-03 ES ES01998306T patent/ES2240570T3/es not_active Expired - Lifetime
- 2001-12-03 CZ CZ20031503A patent/CZ20031503A3/cs unknown
- 2001-12-03 HU HU0302154A patent/HU229546B1/hu not_active IP Right Cessation
- 2001-12-03 AU AU1741602A patent/AU1741602A/xx active Pending
- 2001-12-03 EA EA200300614A patent/EA006632B1/ru not_active IP Right Cessation
-
2003
- 2003-05-19 HR HR20030400A patent/HRP20030400A2/hr not_active Application Discontinuation
- 2003-05-23 BG BG107845A patent/BG107845A/bg unknown
- 2003-05-25 IL IL156100A patent/IL156100A/en not_active IP Right Cessation
- 2003-05-30 MA MA27186A patent/MA25925A1/fr unknown
- 2003-06-02 NO NO20032491A patent/NO324847B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20032491L (no) | Krystallinsk glukosamin sulfat metall salter | |
| MX2009003305A (es) | Inhibidores de co-transportador de glucosa de sodio 2 y metodo para su uso. | |
| TN2009000177A1 (en) | Combination therapy with sglt-2 inhibitors and their pharmaceutical compositions | |
| NO20073831L (no) | Medikamenter for behandling eller forebygging av fibrotiske sykdommer | |
| NO20063928L (no) | Substituerte kinolinforbindelser | |
| MY160123A (en) | Pharmaceutical composition comprising a sglt2 inhibitor, a dpp-iv inhibitor and optionally a further antidiabetic agent and uses thereof | |
| EA201290267A1 (ru) | Производные диоксабицикло[3.2.1]октан-2,3,4-триола | |
| NO20083562L (no) | Cannabinoidreseptormodulatorer | |
| MA33838B1 (fr) | Forme amorphe et cristalline de l'hémitartrate de genz 112638 au titre d'inhibiteur de la glucosylcéramide synthétase | |
| EA200600041A1 (ru) | Применение изомальта (смеси 1,6-gps и 1,1-gpm) в качестве пребиотика, в частности, для получения лекарственного средства для лечения кишечных заболеваний | |
| BR0317803A (pt) | Derivados de benzamidas como inibidores de receptor p2x7 para o tratamento de doenças inflamatórias | |
| BR112013020620A2 (pt) | análogos de ácido 4-hidroxibutírico | |
| UA109774C2 (uk) | Кристалічні форми саксагліптину та процес його одержання (варіанти) | |
| EA201101189A1 (ru) | Ингибитор sglt-2, предназначенный для лечения сахарного диабета типа 1, сахарного диабета типа 2, нарушенной толерантности к глюкозе или гипергликемии | |
| NZ581390A (en) | Prebiotics comprising an oligosaccharide, sialyloligosaccharide and free sialic acid | |
| NO20061541L (no) | Behandling av gastroparese og ikke-ulceros dyspepsi med GABAB-agonister | |
| EA200701889A1 (ru) | ПРОМЕЖУТОЧНОЕ СОЕДИНЕНИЕ И СПОСОБ ПОЛУЧЕНИЯ ОБОГАЩЕННЫХ β-АНОМЕРОМ 2-ДЕЗОКСИ-2,2-ДИФТОР-D-РИБОФУРАНОЗИЛНУКЛЕОЗИДОВ | |
| NO20073550L (no) | Hydantoinderivater nyttige som metallproteinaseinhibitorer | |
| BRPI0508927A (pt) | compostos úteis para o tratamento de doenças | |
| EP2597083A3 (en) | Selective hydroxamate based MMP inhibitors | |
| WO2011070592A3 (en) | Novel sugar derivatives as sglt2 inhibitors | |
| LT2003051A (en) | Crystalline glucosamine sulphate metal salts and process for preparing the same | |
| ZA200803809B (en) | N-sulfamoyl-N'-benzopyranpiperidines as inhibitors of carbonic anhydrases | |
| FR2871800B1 (fr) | Sel de sodium monohydrate du s-tenatoprazole et application en therapeutique | |
| ECSP034670A (es) | Sales de metal cristalinas de sulfato de glucosamina y procedimientos para su preparacion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: PIRAMAL ENTERPRISES LTD, IN |
|
| MM1K | Lapsed by not paying the annual fees |